EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 364 filers reported holding EXELIXIS INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $799,842 | +110.2% | 35,596 | +122.0% | 0.00% | 0.0% |
| Q1 2024 | $380,558 | +43.8% | 16,037 | +45.4% | 0.00% | – |
| Q4 2023 | $264,634 | -2.7% | 11,031 | -11.4% | 0.00% | – |
| Q3 2023 | $271,901 | -19.5% | 12,444 | -29.6% | 0.00% | -100.0% |
| Q2 2023 | $337,884 | +44.0% | 17,681 | +20.8% | 0.00% | – |
| Q4 2022 | $234,697 | -76.5% | 14,632 | -77.0% | 0.00% | -100.0% |
| Q3 2022 | $997,000 | +195.0% | 63,580 | +291.3% | 0.00% | +100.0% |
| Q2 2022 | $338,000 | -23.4% | 16,248 | -16.4% | 0.00% | 0.0% |
| Q1 2022 | $441,000 | +22.5% | 19,432 | -1.3% | 0.00% | 0.0% |
| Q4 2021 | $360,000 | -11.3% | 19,690 | +2.4% | 0.00% | 0.0% |
| Q3 2021 | $406,000 | +8.6% | 19,225 | -6.2% | 0.00% | 0.0% |
| Q2 2021 | $374,000 | -36.2% | 20,505 | -21.0% | 0.00% | 0.0% |
| Q1 2021 | $586,000 | +9.5% | 25,959 | -2.6% | 0.00% | 0.0% |
| Q4 2020 | $535,000 | -18.9% | 26,654 | -1.2% | 0.00% | -50.0% |
| Q3 2020 | $660,000 | +3.6% | 26,987 | +0.5% | 0.00% | 0.0% |
| Q2 2020 | $637,000 | +118.9% | 26,848 | +62.5% | 0.00% | +100.0% |
| Q4 2019 | $291,000 | -9.9% | 16,522 | -9.5% | 0.00% | 0.0% |
| Q3 2019 | $323,000 | -17.6% | 18,263 | -0.4% | 0.00% | -50.0% |
| Q2 2019 | $392,000 | -5.5% | 18,333 | +5.1% | 0.00% | 0.0% |
| Q1 2019 | $415,000 | +37.4% | 17,444 | +13.7% | 0.00% | 0.0% |
| Q4 2018 | $302,000 | -4.4% | 15,336 | -14.0% | 0.00% | +100.0% |
| Q3 2018 | $316,000 | -28.7% | 17,835 | -13.4% | 0.00% | -50.0% |
| Q2 2018 | $443,000 | +13.3% | 20,599 | +16.7% | 0.00% | 0.0% |
| Q1 2018 | $391,000 | -6.9% | 17,651 | +27.7% | 0.00% | -33.3% |
| Q4 2017 | $420,000 | +78.0% | 13,817 | +41.7% | 0.00% | +50.0% |
| Q3 2017 | $236,000 | – | 9,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |